Cargando…
RBM15 condensates modulate m(6)A modification of STYK1 to promote tumorigenesis
RBM15 expression is recurrently upregulated in several types of malignant tissues, and its high expression level is typically associated with poor prognosis. However, whether and how RBM15 is involved in the tumor progression remains unclear. In this study, we found that overexpressing RBM15 in NIH3...
Autores principales: | Jiang, Amin, Zhang, Siwei, Wang, Xinyu, Li, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464649/ https://www.ncbi.nlm.nih.gov/pubmed/36147665 http://dx.doi.org/10.1016/j.csbj.2022.08.068 |
Ejemplares similares
-
Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells
por: Zhou, Jianping, et al.
Publicado: (2017) -
Circ‐CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15
por: Yang, Feng, et al.
Publicado: (2022) -
RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
por: Cai, Xianlei, et al.
Publicado: (2021) -
Aberrant STYK1 expression in ovarian cancer tissues and cell lines
por: Jackson, Kesmic A, et al.
Publicado: (2009) -
Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018)